Amgen Inc.

Becton Dickinson and Company Limited

Kimberly-Clark Worldwide, Inc.

Cvs Pharmacy, Inc. a Rhode Island Corporation

Margaux Frances Boyaval

Masamichi Udagawa

Sigrid G Moeslinger

Mark Joseph Guarraia

Ryan James Shafer

Jared Schneider

Brian Stonecipher

Lisa Nugent

Avon Kuo

Louis Petit

Sheldon B Moberg

Ian B Hanson

Scott Robert Gibson

Paul F Bente, Iv

Kevin Lee Bokelman

John Christian Love

Daniel Shawn Codd

Sean M O'connor

Rajan Ramaswamy

Matthew J Clemente

Scott Beaver

Mark A Destefano

Basel Hasan Taha

Gerhard Andrew Foelsche

Luke Hagan

Adrienne Rae Loyd

Thomas Andrew Lutzow

Peter V Shultz

Melissa Jean Dennis

James Chan

Richard A Cronenberg

Daniel Davenport

Lawton Laurence

Ryan Michael Agard

Gautam N Shetty

Nicholas J Ciccarelli

Antonio Ubach

Robert Decker

Ian P Dardani

Danielle Feldman

Jean-Yves Corbin

Aidan Petrie

Daniel J Nelsen

Gregg Allen Flender

Allan Lee Cameron

John Anthony Vassallo

Christian Plambech

Matias Melander

Joshua Jay Dudman

Michael Sorensen

Maxwell Franklin Bischoff

W Gordon Beecroft

Bjarke Lykke Ludvig Svendsen

Chad E Rice

Joseph J Bruchman

Suzanne M Carmody

Brian Dombrowski

John C Love

Daniel S Codd

Iv Bente Paul F

Scott R Gibson

Kevin L Bokelman

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.

Drug delivery device, method of manufacture, and method of use

Drug delivery devices are described that provide hybrid forms with optional gripping functionalities. For example, the devices can include a grip portion on a skin contact surface with a release liner disposed thereon. A user can operate the devices with the release liner disposed on the grip portion or can remove the release liner so that the grip portion is able to aid users in orienting and supporting the device during an injection operation.

Hybrid drug delivery devices with optional grip portion and related method of preparation

On-body injector

Autoinjector with removable cap

Drug delivery devices are described that provide hybrid forms with gripping and stability functionalities, such as a grip portion on a skin contact surface. In some versions, the drug delivery devices can include a cep having a release liner such that removal of the cap exposes the grip portion. In some versions, the drug delivery devices include a retractable needle guard having the grip portion extending therearound.

Hybrid drug delivery devices with grip portion

Drug delivery devices and related arrangements are disclosed. A drug delivery device may include a housing having an opening, a drug storage container including a delivery member with an insertion end configured to extend at least partially through the opening, and a plunger. A drive mechanism may be included for driving the plunger in a distal direction to expel a drug from the drug storage container through the delivery member upon activation. The drug delivery device may additionally include a guard moveably disposed adjacent to the opening and operably coupled to the drive mechanism for activation of the drive mechanism. A lock may be selectively engageable with the guard to limit movement of the guard in the proximal direction. An indicator may be coupled to the drive mechanism to generate an audible signal during drug delivery, and to cease generating the audible signal when drug delivery is complete.

Drug delivery device

Delivery devices for administering drugs are disclosed. An example apparatus, includes a body including: a handle in which a syringe assembly is to be disposed; a base having a bottom face to be disposed adjacent a user; and an absorbent material attached to the bottom face, the absorbent material structured to hold a fluid to be released onto the user prior to or during an injection procedure.

Delivery devices for administering drugs

A wearable drug delivery device includes an injector having a housing, a reservoir, a needle or cannula, a drive mechanism for urging drug product out of the reservoir, through the needle or cannula, and to a patient, and an activator mechanism disposed on a surface of the housing for activating the drive mechanism. An activation prevention mechanism is coupled to the injector housing and/or activation prevention mechanism to prevent inadvertent actuation of the activator mechanism.

Drug delivery device with activation prevention feature

Wearable drug delivery device

Growing community of inventors

Newbury Park, CA, United States of America

Margaux Frances Boyaval